How real-world evidence can directly support innovation
For decades, randomised controlled trials (RCTs) have been considered the gold standard of clinical research. But as healthcare data becomes…
All articles by Irena Maragkou
Irena Maragkou
Irena Maragkou is a Healthcare Researcher for Clinical Trials Arena and Pharmaceutical Technology based in London, UK. Irena previously worked in consulting at Deloitte’s Strategy, M&A and Analytics Department, focusing on projects in the Pharmaceutical and Healthcare Sector. She holds an MSci degree in Neuroscience from UCL.
-
-
How wearables can unlock their full potential in clinical research
In recent years, wearable devices that track sleep, activity, heart rate, and recovery through smartwatches, fitness bands, and rings have…
-
How to tackle regulatory pathways and obstacles for clinical trials in UK and Ireland
The upcoming Outsourcing in Clinical Trials UK & Ireland 2026 conference, taking place on 9–10 June 2026 in London, UK,…
-
Pivoting to community-based research models to boost patient access
The South Korean government’s ambition to become a top three global clinical trial hub by 2030 is reshaping how the…
-
South Korea and Australia offer solutions for radiopharma trial bottlenecks
In the context of the increasing prevalence of chronic diseases, the global radiopharmaceutical market is gaining momentum and is projected…
-
UAE positions itself as a regional leader and a clinical trial hub
The UAE is quickly advancing its precision medicine and genomics capabilities, establishing itself as a major emerging global clinical trial…
-
Increasing trial activity in APAC region influences commercial supply chains
The Asia-Pacific (APAC) clinical trial landscape is undergoing a shift, with clinical trial activity rising two to three times faster…
-
Emerging trends shape South Korea’s clinical trial ecosystem and supply chains
At the upcoming Outsourcing in Clinical Trials (OCT) and Clinical Trial Supply (CTS) Korea 2025 meetings, which will take place…
-
Investor focus shifts to late-stage development in biotech, expert says
The biotech sector has faced a challenging first half of 2025, underperforming relative to the broader tech industry and the…
-
Driving digital solutions through rapid experimentation
“In the future, 30% of trial data will come from the clinic, while 70% will be sourced by decentralised clinical…